Arcus Biosciences, Inc. (RCUS)
23.83
+0.60
(+2.58%)
USD |
NYSE |
Dec 31, 16:00
23.86
+0.03
(+0.13%)
After-Hours: 20:00
Arcus Biosciences Free Cash Flow: -464.00M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.162B |
| Actinium Pharmaceuticals, Inc. | -25.04M |
| Madrigal Pharmaceuticals, Inc. | -164.63M |
| Karyopharm Therapeutics, Inc. | -89.30M |
| Janux Therapeutics, Inc. | -71.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -97.00M |
| Cash from Investing (Quarterly) | 79.00M |
| Cash from Financing (Quarterly) | 8.00M |
| Free Cash Flow Per Share (Quarterly) | -0.9108 |
| Free Cash Flow to Equity (Quarterly) | -99.00M |
| Free Cash Flow to Firm (Quarterly) | -94.00M |
| Free Cash Flow Yield | -19.32% |